Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00900016 · ClinicalTrials.gov registry record
Studying Fibroblast Activity in Patients With Localized Pancreatic Cancer Undergoing Surgery
A clinical trial, sponsored by Fox Chase Cancer Center.
- Completed
- Registry status
- 37
- Enrollment target
NCT00900016: Completed study, sponsored by Fox Chase Cancer Center.
NCT00900016 is a clinical trial that has completed, run by Fox Chase Cancer Center. The registered enrollment target is 37 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00900016 has completed, sponsored by Fox Chase Cancer Center.
- COMPLETED
- Registry status
- 37 participants
- Enrollment target
Study Summary
RATIONALE: Studying samples of tumor tissue and blood from patients with cancer in the laboratory may help doctors learn more about changes that occur in DNA and identify biomarkers related to cancer. PURPOSE: This research study is assessing fibroblast activity in patients with localized pancreatic cancer undergoing surgery.
Interventions
- GENETIC protein expression analysis
- OTHER laboratory biomarker analysis
- OTHER immunohistochemistry staining method
- GENETIC western blotting
- OTHER immunologic technique
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 37 participants |
| Start Date | 2007-08 |
| Est. Completion | 2017-06-23 |
What the finished NCT00900016 record still lists
NCT00900016 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 37 participants, a relatively small participant target.
The record links to 0 conditions, and to 5 interventions - of which protein expression analysis is the first listed.
NCT00900016 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00900016 about?
NCT00900016 is a clinical study titled "Studying Fibroblast Activity in Patients With Localized Pancreatic Cancer Undergoing Surgery". RATIONALE: Studying samples of tumor tissue and blood from patients with cancer in the laboratory may help doctors learn more about changes that occur in DNA and identify biomarkers related to cancer. PURPOSE: This research study is assessing fibroblast activity in patients with localized pancreati...
What is the current status of trial NCT00900016?
This trial is currently completed. The enrollment target is 37 participants. The study started on 2007-08. Estimated completion is 2017-06-23.
What interventions are being tested in trial NCT00900016?
The interventions under investigation include: protein expression analysis (GENETIC), laboratory biomarker analysis (OTHER), immunohistochemistry staining method (OTHER), western blotting (GENETIC), immunologic technique (OTHER).
Who is sponsoring clinical trial NCT00900016?
This trial is sponsored by Fox Chase Cancer Center, which has 183 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02800486 · 37 participants · Phase 2
Super Selective Intra-arterial Repeated Infusion of Cetuximab (Erbitux) With Reirradiation for Treatment of Relapsed/Refractory GBM, AA, and AOA
- NCT03173937 · 37 participants · Phase 1
Unrelated Umbilical Cord Blood Transplantation for Severe Aplastic Anemia and Hypo-plastic MDS Using CordIn(TM), Umbilical Cord Blood-Derived Ex Vivo Expanded Stem and Progenitor Cells to Expedite Engraftment and Improve Transplant Outcome
- NCT03295227 · 37 participants · Phase 1
Pembrolizumab in Treating Participants With Unresectable Thymoma or Thymic Cancer
- NCT03401047 · 37 participants · Early Phase 1
Study to Assess Potential Impairments in Estradiol Augmentation of Gonadotropin Secretion in Polycystic Ovary Syndrome
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia